HMOX1 and cancer: A facile and high‐efficiency sequential catalytic therapy is as follows: First, QE and Znpp IX pre‐release from MCPQZ to overcome thermal resistance and antioxidant defense of cancer cells by downregulating the expression of HSP70 and activity of HO‐1, respectively, building a favorable microenvironment for subsequent thermal and ROS injury.